Valuation: Sopharma AD

Market Cap 1.95B 1.17B 1.02B 953M 871M 1.64B 112B 1.67B 11.14B 4.37B 55.79B 4.4B 4.31B 186B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.49B 1.5B 1.3B 1.22B 1.11B 2.1B 143B 2.13B 14.23B 5.59B 71.26B 5.62B 5.5B 237B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day+0.26%
1 week+1.85%
1 month-0.52%
3 months+8.45%
6 months+0.79%
Current year+35.13%
1 week 1.9
Extreme 1.9
1.93
1 month 1.84
Extreme 1.845
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.23
Extreme 1.232419
2
3 years 0.92
Extreme 0.920558
2
5 years 0.58
Extreme 0.579207
2
10 years 0.41
Extreme 0.408688
2
Manager TitleAgeSince
Chief Executive Officer 42 30/09/2000
Director of Finance/CFO - 31/12/2001
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 18/05/2010
Director/Board Member 63 18/05/2010
Director/Board Member 61 11/07/2011
Date Insider Type Main position Quantity % Market Cap.
30/09/20
Donev Investments Ad
BuyCompany 25,489 0.0189%
30/09/20 Buy

Chief Executive Officer

12,000 0.0089%
29/09/20
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+1.85%+53.03%+106.90% 1.17B
-0.66%-1.17%-24.83%-27.35% 15.94B
+2.14%-0.28%-27.82%-35.84% 7.22B
+1.63%-1.78%-25.75%-7.35% 6.08B
-0.66%-1.01%-8.29%-31.89% 4.04B
-0.73%+0.16%-22.79%-41.16% 3.3B
+1.06%+0.48%-41.34%-22.86% 3.13B
-1.92%-6.38%+1.59%-39.00% 3.02B
+0.06%-4.37%-14.55%+3.29% 2.61B
-2.54%-4.20%+88.49% - 2.5B
Average -0.14%-2.30%-2.23%-10.58% 4.9B
Weighted average by Cap. +0.03%-1.92%-15.12%-22.78%

Financials

2024 2025
Net sales 2.14B 1.28B 1.12B 1.04B 955M 1.8B 122B 1.83B 12.22B 4.79B 61.16B 4.82B 4.72B 204B 2.63B 1.58B 1.37B 1.28B 1.18B 2.22B 151B 2.25B 15.03B 5.9B 75.26B 5.94B 5.81B 250B
Net income 77.85M 46.75M 40.57M 37.99M 34.75M 65.61M 4.45B 66.47M 444M 174M 2.23B 176M 172M 7.41B 134M 80.19M 69.59M 65.16M 59.61M 113M 7.64B 114M 762M 299M 3.82B 301M 295M 12.7B
Net Debt 444M 267M 232M 217M 198M 374M 25.41B 379M 2.54B 995M 12.7B 1B 980M 42.26B 541M 325M 282M 264M 242M 456M 30.97B 462M 3.09B 1.21B 15.47B 1.22B 1.19B 51.5B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
06/08/26 €1.925 +0.26% 4,177
05/08/26 €1.920 +0.26% 1,486
04/08/26 €1.915 -0.52% 7,735
03/08/26 €1.925 0.00% 2,200
31/07/26 €1.925 +1.85% 4,119

Annual profits - Rate of surprise